Necrotic Enteritis (Clostridium perfringens Type A & C)

Necrotic enteritis (NE) is an acute, often fatal, toxicoinfectious disease of poultry, primarily affecting broiler chickens, characterized by severe necrosis of the intestinal mucosa, particularly the jejunum and ileum, due to the overgrowth and toxin production of Clostridium perfringens, predominantly type A and less commonly type C. The disease manifests in two forms: clinical (acute) and subclinical (chronic). The clinical form is marked by sudden onset, high mortality, and characteristic gross lesions of the small intestine, while the subclinical form results in impaired digestion, reduced weight gain, and decreased feed conversion efficiency, leading to significant economic losses. NE is a major concern in the global poultry industry, especially in intensive broiler production systems, and is often associated with predisposing factors such as coccidiosis, dietary changes, and immunosuppression. The disease is also reported in turkeys, ducks, and other avian species, but broiler chickens are the most susceptible. The pathogenesis involves the proliferation of C. perfringens in the small intestine, followed by the production of alpha-toxin (phospholipase C) and, in type C strains, beta-toxin, which cause mucosal necrosis and systemic toxemia. Control strategies focus on prevention through management, nutrition, vaccination, and the use of antimicrobials, though antibiotic resistance is an emerging concern.

The primary causative agent of necrotic enteritis is Clostridium perfringens, a Gram-positive, anaerobic, spore-forming rod. C. perfringens is classified into five toxinotypes (A, B, C, D, E) based on the production of four major toxins (alpha, beta, epsilon, iota). In poultry, type A is the most common, producing alpha-toxin (CPA), a phospholipase C that hydrolyzes lecithin in cell membranes, leading to cell lysis and tissue necrosis. Type C strains produce beta-toxin (CPB), which is highly necrotizing and contributes to the severe intestinal lesions seen in some outbreaks. Additionally, a novel toxin, NetB (Necrotic Enteritis toxin B), has been identified in many field isolates and is considered a key virulence factor in the pathogenesis of NE, causing necrosis of enterocytes. Other potential virulence factors include perfringolysin O, collagenases, and hyaluronidases, which facilitate tissue invasion. The bacterium is ubiquitous in the environment, soil, dust, feces, and feed, and is a normal inhabitant of the intestinal tract of healthy birds, but under favorable conditions, it proliferates rapidly and produces toxins. The spores are highly resistant to heat, desiccation, and disinfectants, making eradication difficult. The disease is not transmitted horizontally between birds but is triggered by factors that disrupt the intestinal microbiota, such as coccidiosis, dietary stress, or immunosuppression.

Necrotic enteritis is a worldwide disease, with a higher prevalence in broiler chickens raised on deep litter systems, particularly in intensive production areas. The disease is most commonly seen in broilers aged 2 to 6 weeks, with a peak incidence around 3 to 4 weeks of age. It is less common in layers and breeders, but can occur in young pullets and occasionally in adult birds. Turkeys are also susceptible, but the disease is less frequent. The morbidity rate can range from 10% to 40%, and mortality can reach 50% in severe outbreaks, though typical mortality is 2% to 10%. The subclinical form is more economically significant, causing reduced weight gain (5-15%), impaired feed conversion ratio (FCR) by 0.02-0.05, and increased condemnation at slaughter. The disease is often precipitated by predisposing factors such as coccidiosis (especially Eimeria maxima, E. acervulina, and E. necatrix), which damage the intestinal mucosa and provide a protein-rich environment for C. perfringens growth. Dietary factors, including high levels of wheat, barley, rye, or fish meal, and diets with high viscosity, can increase the risk. Poor management practices, such as high stocking density, poor litter quality, wet litter, and inadequate ventilation, also contribute. The disease is more common in the summer months, possibly due to higher environmental temperatures and humidity. Biosecurity lapses, such as contaminated feed or water, can introduce the organism, but the disease is primarily endogenous, arising from the bird's own intestinal flora.

The pathogenesis of necrotic enteritis is a multifactorial process. Initially, predisposing factors such as coccidiosis cause damage to the intestinal epithelium, leading to the leakage of plasma proteins and amino acids into the lumen, which serve as nutrients for C. perfringens. The disruption of the normal gut microbiota, often due to dietary changes or antibiotic use, allows C. perfringens to proliferate rapidly. The bacteria adhere to the intestinal mucosa, particularly in the jejunum and ileum, and produce toxins. Alpha-toxin (CPA) acts as a phospholipase C, cleaving phosphatidylcholine in cell membranes, leading to cell lysis and necrosis. NetB toxin forms pores in the enterocyte membranes, causing cell death. Type C beta-toxin is also necrotizing. The toxins cause extensive necrosis of the villi and crypts, leading to a loss of absorptive surface, hemorrhage, and the formation of a pseudomembrane composed of fibrin, necrotic debris, and bacteria. The intestinal wall becomes thickened, edematous, and friable. In severe cases, the toxins can be absorbed systemically, causing toxemia, liver damage, and death. The subclinical form is characterized by milder, focal lesions that do not cause mortality but impair digestion and absorption, leading to reduced growth performance. The immune response is primarily humoral, with antibodies against alpha-toxin and NetB, but these are not fully protective. The disease can also lead to cholangiohepatitis, a chronic liver condition, due to the migration of C. perfringens to the liver via the portal circulation.

Several intrinsic and extrinsic factors predispose poultry to necrotic enteritis. Intrinsic factors include age (young birds are more susceptible), genetic susceptibility (fast-growing broiler strains are more prone), and immune status (immunosuppression from infectious bursal disease, Marek's disease, or mycotoxins increases risk). High production stress, such as rapid growth rate, can also increase susceptibility. Extrinsic factors are numerous: coccidiosis is the most significant, as it damages the intestinal mucosa and provides nutrients for C. perfringens. Dietary factors include high levels of soluble non-starch polysaccharides (NSPs) from wheat, barley, or rye, which increase intestinal viscosity and slow digesta passage, promoting bacterial overgrowth. High protein diets, especially those containing fish meal, provide amino acids that favor C. perfringens growth. Poor management practices, such as high stocking density, poor litter quality (wet, caked litter), inadequate ventilation leading to high ammonia levels, and poor biosecurity, all contribute. Feed contamination with C. perfringens or its spores, and water contamination, can introduce the organism. The use of certain anticoccidial drugs, especially ionophores, can alter the gut microbiota and predispose to NE. Stress from handling, vaccination, or environmental changes can also trigger outbreaks. Additionally, the withdrawal of growth-promoting antibiotics in some regions has been associated with an increased incidence of NE.

The clinical signs of necrotic enteritis can be acute or subclinical. In the acute form, birds may be found dead without prior signs, often with a sudden increase in mortality. Affected birds appear depressed, with ruffled feathers, drooping wings, and a reluctance to move. They may show a drop in feed and water intake. Diarrhea is common, with feces being watery, brownish, or containing undigested feed particles. The vent area may be soiled with feces. As the disease progresses, birds become emaciated, dehydrated, and may show signs of toxemia, such as pale combs and wattles. In severe cases, neurological signs such as incoordination and tremors may occur due to toxemia. In the subclinical form, there are no obvious clinical signs, but the flock shows reduced weight gain, poor feed conversion, and increased condemnation at slaughter due to liver lesions (cholangiohepatitis). In layers, there may be a drop in egg production, but this is less common. The disease can also cause a transient increase in mortality in turkeys, with similar signs. It is important to note that clinical signs are non-specific and can be confused with other enteric diseases, so necropsy is essential for diagnosis.

Differential diagnoses for necrotic enteritis include: 1) Coccidiosis (Eimeria spp.): Coccidiosis causes intestinal lesions that may be similar, but coccidiosis typically presents with bloody diarrhea and characteristic mucosal lesions (petechiae, white plaques) that are distinguishable on necropsy. Coccidial oocysts can be identified on fecal smears. 2) Ulcerative enteritis (Clostridium colinum): This disease causes similar intestinal ulcers, but lesions are more common in the ceca and large intestine, and the liver may have necrotic foci. 3) Salmonellosis (Salmonella spp.): Systemic infection can cause enteritis, but Salmonella is more often associated with septicemia, and the organism can be cultured from liver and spleen. 4) Avian intestinal spirochetosis (Brachyspira spp.): This causes mild enteritis and diarrhea, but lesions are less severe. 5) Viral enteritis (e.g., rotavirus, coronavirus): These cause diarrhea and intestinal lesions, but are less necrotizing. 6) Histomoniasis (Histomonas meleagridis): This causes cecal cores and liver lesions, but primarily affects turkeys. 7) Intestinal parasitism (e.g., Ascaridia, Heterakis): These can cause enteritis, but are less common in modern production. 8) Mycotoxins (e.g., T-2 toxin): These can cause oral lesions and enteritis, but are not associated with the characteristic pseudomembrane. 9) Necrotic enteritis must also be differentiated from other clostridial diseases such as gangrenous dermatitis, which affects the skin and muscles. Diagnosis is based on necropsy findings, histopathology, and isolation of C. perfringens from intestinal lesions.

The diagnostic algorithm for necrotic enteritis begins with a thorough flock history, including age, mortality, clinical signs, feed changes, and recent coccidiosis outbreaks. Clinical observation of the flock may reveal depression, diarrhea, and increased mortality. The next step is a complete necropsy of several affected birds. Gross lesions are characteristic: the small intestine, especially the jejunum and ileum, is dilated, friable, and has a thickened wall. The mucosa is covered with a grayish-green or yellow pseudomembrane, which may be patchy or diffuse. The intestinal contents are often brownish and foul-smelling. The liver may be enlarged and congested, and in chronic cases, may show cholangiohepatitis. Histopathology of the intestine shows severe necrosis of the mucosa, with fibrin and bacterial colonies. For confirmation, anaerobic culture of the intestinal contents or lesions on blood agar can isolate C. perfringens, and toxinotyping (PCR for alpha, beta, and NetB toxins) can be performed. PCR can also detect the presence of C. perfringens and its toxin genes directly from intestinal samples. Serology is not commonly used for diagnosis, but ELISA can detect antibodies to alpha-toxin, which may be useful for monitoring. Differential diagnosis is important to rule out coccidiosis, which can be done by examining intestinal scrapings for oocysts. A scoring system for gross lesions (0-4) can be used to assess severity. The diagnosis is typically based on the combination of clinical signs, necropsy lesions, and laboratory confirmation.

Laboratory findings in necrotic enteritis include: 1) Microbiology: Anaerobic culture of intestinal contents or mucosal scrapings on blood agar yields C. perfringens, which is confirmed by Gram stain (Gram-positive rods) and biochemical tests. Toxinotyping via PCR detects genes for alpha-toxin (cpa), beta-toxin (cpb), and NetB (netB). 2) Molecular diagnostics: Real-time PCR can quantify C. perfringens and detect toxin genes directly from intestinal samples, providing rapid confirmation. 3) Histopathology: Microscopic examination of the intestine shows severe mucosal necrosis, with fibrin, necrotic debris, and large numbers of Gram-positive bacilli. The lamina propria is infiltrated with heterophils and macrophages. 4) Hematology: Blood tests may show leukocytosis with a left shift, and elevated liver enzymes (AST, ALT) in cases of liver involvement. 5) Serology: ELISA for antibodies to alpha-toxin or NetB can be used for flock monitoring, but is not diagnostic. 6) Feed analysis: Mycotoxin assays (e.g., T-2 toxin, vomitoxin) may be performed to rule out mycotoxicosis. 7) Coccidiosis lesion scoring: Intestinal scrapings can be examined for oocysts, and lesion scores (0-4) can be assigned to assess the severity of coccidiosis, which is a common predisposing factor. 8) Blood chemistry: In chronic cases, elevated bile acids and bilirubin may indicate cholangiohepatitis. These laboratory findings, combined with necropsy, provide a definitive diagnosis.

Imaging is not commonly used in the diagnosis of necrotic enteritis in poultry, as the disease is typically diagnosed at necropsy. However, in a research setting, imaging modalities such as radiography and ultrasonography may be used to assess intestinal changes. Radiography of affected birds may show gas-filled loops of intestine, but this is non-specific. Ultrasonography could reveal thickening of the intestinal wall and the presence of fluid, but these findings are also non-specific. In practice, gross necropsy photography is the most valuable imaging tool, as it allows for documentation of the characteristic lesions, such as the pseudomembrane and intestinal dilation. These images can be used for educational purposes and for comparison in diagnostic cases. Advanced imaging techniques such as computed tomography (CT) or magnetic resonance imaging (MRI) are not used in poultry due to cost and practicality. Therefore, imaging plays a minimal role in the diagnosis of necrotic enteritis, and the focus is on gross and microscopic pathology.

Cytology and histopathology are essential for confirming necrotic enteritis. On cytology, impression smears of the intestinal mucosa may show large numbers of Gram-positive rods, often in chains, along with necrotic debris and inflammatory cells. Histopathology of the small intestine reveals severe coagulative necrosis of the villi and crypts, with loss of the epithelial lining. The mucosa is covered by a pseudomembrane composed of fibrin, necrotic cells, and bacterial colonies. The lamina propria is edematous and infiltrated with heterophils, macrophages, and lymphocytes. In the submucosa, there may be congestion and hemorrhage. The muscularis may be thickened. In chronic cases, the liver may show cholangiohepatitis, characterized by periportal inflammation, bile duct hyperplasia, and fibrosis. The presence of Gram-positive bacilli within the necrotic tissue is pathognomonic. Special stains, such as Gram stain, can highlight the bacteria. Immunohistochemistry can be used to detect C. perfringens antigens. The lesion score (0-4) can be used to grade the severity of the intestinal lesions, with 0 being normal and 4 being severe necrosis with pseudomembrane formation. Histopathology is also useful to rule out other causes of enteritis, such as coccidiosis, which would show the presence of coccidial stages in the mucosa.

Treatment of necrotic enteritis should be initiated immediately upon diagnosis to reduce mortality and economic losses. The primary approach is the administration of antimicrobials effective against C. perfringens, either in drinking water or feed. Commonly used antibiotics include amoxicillin (10-20 mg/kg body weight, or 100-200 mg/L drinking water for 3-5 days), oxytetracycline (10-20 mg/kg, or 200-400 mg/L drinking water for 3-5 days), tylosin (20-50 mg/kg, or 500 mg/L drinking water for 3-5 days), and lincomycin (20-40 mg/kg, or 100-200 mg/L drinking water for 3-5 days). Bacitracin methylene disalicylate (BMD) is often used in feed at 50-100 g/ton for prevention and treatment. In some countries, florfenicol (20-30 mg/kg, or 200-400 mg/L drinking water for 3-5 days) and enrofloxacin (10-20 mg/kg, or 100-200 mg/L drinking water for 3-5 days) may be used, but their use is restricted in some regions due to concerns about antibiotic resistance. Supportive therapy includes the addition of electrolytes, vitamins (especially vitamin A, D3, E, and C), and probiotics to the water to help restore the gut microbiota. In cases where coccidiosis is a predisposing factor, anticoccidial treatment should be administered, such as amprolium (0.0125% in drinking water for 3-5 days) or toltrazuril (25 mg/L drinking water for 2 days). It is important to improve management practices, such as reducing stocking density, improving litter quality, and ensuring good ventilation. In severe outbreaks, vaccination of the flock may be considered, but there are limited commercial vaccines available. The withdrawal times for antibiotics must be observed to ensure food safety.

The prognosis for necrotic enteritis depends on the severity of the outbreak and the speed of intervention. In acute cases with high mortality, the prognosis is guarded, but with prompt treatment, mortality can be reduced within 24-48 hours. The flock may recover, but there may be long-term effects on growth performance, including reduced weight gain and poor feed conversion. In subclinical cases, the prognosis is good if the predisposing factors are corrected, but the economic impact can be significant due to reduced performance. The recovery of egg production in layers is usually complete, but there may be a temporary drop. The mortality rate can be reduced to less than 1% with appropriate treatment. However, if the disease is not treated, mortality can reach 50%. The prognosis is also influenced by the presence of concurrent diseases, such as coccidiosis or immunosuppressive diseases. In flocks with chronic cholangiohepatitis, the prognosis is poor, as liver damage may be irreversible. Overall, with early detection and treatment, the prognosis is fair to good, but prevention is the best approach.

Follow-up after a necrotic enteritis outbreak is crucial to prevent recurrence and to monitor the recovery of the flock. The flock should be monitored daily for clinical signs, mortality, and feed and water intake. Necropsy of any dead birds should be performed to ensure that the lesions are resolving. A biosecurity audit should be conducted to identify and correct any management deficiencies, such as poor litter quality, high stocking density, or inadequate ventilation. Litter should be removed and replaced, and the house should be cleaned and disinfected thoroughly. The water system should be flushed and sanitized. Feed should be analyzed for mycotoxins and other contaminants. The vaccination program should be reviewed, and adjustments may be made to reduce stress. Serological monitoring for C. perfringens antibodies can be performed to assess the immune status of the flock. In the next flock, preventive measures should be implemented, such as the use of anticoccidials, probiotics, and feed additives like mannan-oligosaccharides (MOS) or organic acids to promote gut health. The use of antimicrobials should be minimized to reduce the risk of resistance. A follow-up visit by a veterinarian should be scheduled to assess the flock's progress and to provide recommendations for future prevention.

Clinical pearls: 1) Necrotic enteritis is often a secondary disease, so always look for predisposing factors, especially coccidiosis. 2) The characteristic pseudomembrane on the intestinal mucosa is pathognomonic, but it can be missed if the intestine is not opened carefully. 3) The subclinical form is more economically important than the clinical form, so monitor performance parameters such as FCR and weight gain. 4) C. perfringens is a normal inhabitant of the gut, so isolation alone is not diagnostic; the presence of lesions is essential. 5) Treatment should be initiated immediately, and the antibiotic should be chosen based on sensitivity testing if possible. 6) Improving gut health through nutrition and management is key to prevention. Pitfalls: 1) Misdiagnosing necrotic enteritis as coccidiosis and treating with anticoccidials alone, which will not be effective. 2) Failing to recognize the subclinical form, leading to economic losses. 3) Using antibiotics with poor efficacy against C. perfringens, such as some sulfonamides. 4) Not addressing the underlying predisposing factors, leading to recurrence. 5) Overusing antibiotics, contributing to antimicrobial resistance. 6) Neglecting biosecurity and hygiene, which can lead to persistent contamination of the environment. 7) Not considering the withdrawal times for antibiotics, leading to residues in meat or eggs.

Current drug protocols for necrotic enteritis are based on the use of antimicrobials, anticoccidials, and supportive therapies. For treatment, the following protocols are recommended: Amoxicillin: 20 mg/kg body weight orally, or 200 mg/L drinking water for 3-5 days. Oxytetracycline: 20 mg/kg, or 200-400 mg/L drinking water for 3-5 days. Tylosin: 50 mg/kg, or 500 mg/L drinking water for 3-5 days. Lincomycin: 20 mg/kg, or 100-200 mg/L drinking water for 3-5 days. Bacitracin methylene disalicylate (BMD): 100-200 g/ton of feed for treatment, and 50-100 g/ton for prevention. Florfenicol: 20-30 mg/kg, or 200-400 mg/L drinking water for 3-5 days (where legal). Enrofloxacin: 10-20 mg/kg, or 100-200 mg/L drinking water for 3-5 days (where legal). For coccidiosis control, amprolium: 0.0125% in drinking water for 3-5 days, or toltrazuril: 25 mg/L drinking water for 2 days. Supportive therapy includes electrolytes and vitamins (A, D3, E, C, K) in drinking water. Probiotics (e.g., Lactobacillus, Bifidobacterium) can be added to the feed or water to restore gut flora. Withdrawal times: Amoxicillin: 1 day for meat, 0 days for eggs; Oxytetracycline: 3 days for meat, 0 days for eggs; Tylosin: 1 day for meat, 0 days for eggs; Lincomycin: 1 day for meat, 0 days for eggs; BMD: 0 days; Florfenicol: 3 days for meat; Enrofloxacin: 3 days for meat. It is important to follow local regulations and veterinary guidance.

Evidence-based literature on necrotic enteritis is extensive. Key studies have established the role of C. perfringens type A and NetB toxin in the pathogenesis. A landmark study by Keyburn et al. (2008) identified NetB as a critical virulence factor, as mutants lacking NetB were unable to cause disease. Field trials have demonstrated that the incidence of NE is higher in flocks with coccidiosis, and the use of anticoccidials can reduce NE risk. A meta-analysis by Gholamiandehkordi et al. (2010) showed that dietary factors, such as wheat and fish meal, increase the risk of NE. The use of probiotics and prebiotics has been shown to reduce NE severity in experimental models. Vaccination studies have shown that immunization with alpha-toxin and NetB toxoids can provide partial protection. The AAAP and WVPA have published consensus guidelines on the diagnosis and management of NE, emphasizing the importance of biosecurity, nutrition, and judicious use of antibiotics. The withdrawal of antibiotic growth promoters in Europe has been associated with an increased incidence of NE, highlighting the need for alternative control strategies. Recent research has focused on the gut microbiome and the use of bacteriophages and organic acids as alternatives to antibiotics. Overall, the literature supports a multifactorial approach to NE control, including management, nutrition, and vaccination.